A burgeoning body of evidence suggests that ferroptosis can be induced in tumor cells through inhibition of System Xc-, depletion of glutathione (GSH), and inactivation of glutathione peroxidase 4 (GPX4), thereby counteracting the mechanisms of drug resistance in breast cancer (6). This evidence concerns the gene GPX4 and breast carcinoma.